��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title A Low Percentage of CD4+ Cells Can Predict Disease Reactivation after Natalizumab Discontinuation

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 063

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Antonio Bertolotto, MD, FAAN (Ospedale Koelliker) PRESENTER	Dr. Bertolotto has nothing to disclose.
	No disclosure on file
Simona Malucchi	No disclosure on file
Alessia Di Sapio	Alessia Di Sapio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Alessia Di Sapio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . Alessia Di Sapio has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Alessia Di Sapio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Alessia Di Sapio has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi . The institution of Alessia Di Sapio has received research support from Ministero della Salute. The institution of Alessia Di Sapio has received research support from Sanofi.
Manuela Matta	No disclosure on file
Maria Malentacchi	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Marco Capobianco, MD	No disclosure on file